And BTW , after 10 weeks with longer overlap they had 0 failure , efficacy was 100% with 700 mg , this is why I believe they will go 5 wks longer as per previous study to see what happen. They possibly could go 1 or 2 week less , but imo 3 weeks on HAART and Leronlimab , plus 5 weeks only Leronlimab should be chosen .... I am talking for 700 mg , time is different as we know with 350 and 525...

This is If company will decide at the end to use longer overlap , and I think they will if results continue to be better...